Furthermore, high proportions of CD8+ T cells in the tumors following chemotherapy—but not of CD4+ TILs—were significantly associated with lower tumor sizes (Figure 3(C2,C3)), indicating that activated CD8+ CTLs played a role in reducing the tumor growth. Here, CD4 is linked to neoplasm.